3 Stocks I Saw on T...
Health Care: Drugs
Cytori Therapeutics Inc. (CYTX: NASDAQ)
$2.13 0.05 | 2.40%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -32.45M | -27.49M | -23.22M | -30.04M |
| Operating Gains/Losses | 209.00K | 151.00K | 44.00K | 45.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -670.00K | -902.00K | -986.00K | -1.42M |
| (Increase) Decrease in Inventories | 60.00K | -777.00K | -446.00K | -2.14M |
| (Increase) Decrease In Other Current Assets | -3.00K | 36.00K | 41.00K | -147.00K |
| (Decrease) Increase In Payables | -1.44M | 811.00K | 413.00K | -2.22M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -2.78M | 707.00K | -8.99M | -2.58M |
| Other Non-Cash Items | 179.00K | 2.26M | 6.94M | 3.39M |
| Net Cash From Continuing Operations | -35.32M | -23.57M | -23.81M | -33.39M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -35.32M | -23.57M | -23.81M | -33.39M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 5.74M |
| Purchases of Property, Plant & Equipment | -560.00K | -610.00K | -221.00K | -393.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -5.74M |
| Other Cash from Investing Activities | 0.00 | -350.00K | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -560.00K | -1.29M | -221.00K | -393.00K |
| Issuance of Debt | 9.44M | 20.00M | 0.00 | 7.50M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 16.14M | 52.61M | 27.66M | 29.75M |
| Repayment of Long-Term Debt | -4.53M | -5.45M | -2.05M | -958.00K |
| Repurchase of Capital Stock | -194.00K | -1.92M | -1.34M | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -719.00K | -559.00K | 0.00 | -1.36M |
| Net Cash From Financing Activities | 20.14M | 64.68M | 24.27M | 34.93M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -15.75M | 39.81M | 243.00K | 1.15M |
Portfolios with CYTX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor6 Drug Stocks Unworthy of B...
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- ContributorStem Cell Stocks
- Usermurphman Portfolio 1
- UserSUPRATRADE HOT STOCKS (BUY ...
Latest CYTX Headlines from TheStreet
- 8 Stocks Under $10 Soaring Higher 05.10.12 | 01:05 pm
- Tuesday's Top 10 Articles, Videos on TheStreet 02.07.12 | 01:02 pm
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- 8 Stocks Under $10 Ripping Higher 01.26.12 | 02:01 pm
- Cytori Therapeutics Inc. (CYTX): Today's Featured Drugs Loser 09.29.11 | 04:09 pm
- Biotech Stock Mailbag: Mela Sciences 09.09.11 | 06:09 am
- Biotech Stock Mailbag: Cytori Therapeutics 05.20.11 | 07:05 am
- Cytori Therapeutics Inc. Stock Downgraded (CYTX) 05.10.11 | 06:05 am
- Cytori Stock Hits New 52-Week High (CYTX) 04.04.11 | 10:04 am
- Cytori Therapeutics Inc. Stock Upgraded (CYTX) 03.24.11 | 06:03 pm
Press Releases for CYTX
- Cytori Therapeutics Announces Independent Clinical Study Results In Breast Reconstruction Presented At The Association Of Breast Surgery Conference - Business Wire 05.17.11 | 05:05 am
- Catholic Healthcare West President/CEO Lloyd H. Dean To Join Cytori Therapeutics’ Board Of Directors - Business Wire 11.03.10 | 07:11 am
- Cytori Announces Exercise In Full Of Overallotment Option And Closing Of Public Offering Of Common Stock; Raises $19.3 Million In Net Proceeds - Business Wire 10.13.10 | 09:10 am
- Cytori Therapeutics Prices Public Offering Of Common Stock - Business Wire 10.08.10 | 08:10 am
- Cytori Therapeutics Proposes Common Stock Public Offering - Business Wire 10.07.10 | 04:10 pm
- Adipose-Derived Stem & Regenerative Cells Reduce Mortality, Improve Renal Function In Preclinical Acute Kidney Injury Study Data Published Today - Business Wire 10.05.10 | 08:10 am
- Cytori Extends Distribution Agreement With GE Healthcare; Key Focus On Research Market - Business Wire 09.16.10 | 07:09 am
- Cytori Therapeutics Announces Fall 2010 U.S. Conference Schedule - Business Wire 09.13.10 | 07:09 am
- Cytori Issued Celution® System Patent For Orthopedic & Spinal Disc Diseases - Business Wire 08.12.10 | 07:08 am
- Cytori’s PureGraft™ System Receives European Approval For Fat Grafting Procedures - Business Wire 07.29.10 | 08:07 am
Partner Headlines for CYTX
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 07.13.11 | 09:07 am
- Cytori Therapeutics: Sales Miss? Yes. Bad Quarter? No - Seeking Alpha 05.06.11 | 03:05 pm
- Some Hidden Gem Stocks That May Have High Returns! - AOL 04.05.11 | 07:04 pm
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- 9 Cheap Stocks Under $10 Making New Price Highs - Seeking Alpha 03.25.11 | 08:03 am
- Options Brief: Cytori Therapeutics (CYTX) - Benzinga 03.17.11 | 01:03 pm
- UPDATE 1-Cytori, Astellas Pharma sign $10 mln equity deal - Reuters 12.07.10 | 07:12 am
